Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIBNASDAQ:BJDXNASDAQ:GMVDNASDAQ:NVIVQ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00+38.9%$0.03$0.00▼$0.22$74K-0.3535,691 shs4,905 shsBJDXBluejay Diagnostics$1.73-3.9%$2.05$1.46▼$214.80$2.58M0.38656,626 shs6,146 shsGMVDG Medical Innovations$0.27$0.14▼$13.83$355KN/A1.13 million shs2.86 million shsNVIVQInvivo Therapeutics$0.37$0.37$0.00▼$0.00$1.15M0.4N/AN/A13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical+38.89%+38.89%-91.78%-94.08%-94.44%BJDXBluejay Diagnostics-1.64%+1.12%+1.12%-54.77%-99.04%GMVDG Medical Innovations0.00%0.00%0.00%0.00%0.00%NVIVQInvivo Therapeutics0.00%0.00%0.00%0.00%+36,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/ABJDXBluejay Diagnostics1.1519 of 5 stars0.05.00.00.02.80.00.6GMVDG Medical InnovationsN/AN/AN/AN/AN/AN/AN/AN/ANVIVQInvivo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/ABJDXBluejay Diagnostics 0.00N/AN/AN/AGMVDG Medical Innovations 0.00N/AN/AN/ANVIVQInvivo Therapeutics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.01N/AN/A($0.03) per share-0.08BJDXBluejay Diagnostics$250K10.33N/AN/A$934.50 per share0.00GMVDG Medical Innovations$4.42M0.00N/AN/A($3.21) per share0.00NVIVQInvivo TherapeuticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-272.74%-311.64%-11.57%N/ABJDXBluejay Diagnostics-$9.95M-$379.74N/A∞N/AN/A-155.67%-117.82%N/AGMVDG Medical Innovations-$24.63MN/A0.00N/AN/AN/AN/AN/AN/ANVIVQInvivo Therapeutics-$10.49MN/A0.00∞N/AN/AN/AN/AN/ALatest GMVD, NVIVQ, BJDX, and AFIB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025BJDXBluejay DiagnosticsN/A-$3.37N/A-$3.37N/AN/A3/31/2025Q4 2024BJDXBluejay Diagnostics-$36.00-$112.37-$76.37-$112.37N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/ABJDXBluejay DiagnosticsN/AN/AN/AN/AN/AGMVDG Medical InnovationsN/AN/AN/AN/AN/ANVIVQInvivo TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57BJDXBluejay DiagnosticsN/A6.266.26GMVDG Medical InnovationsN/A0.220.19NVIVQInvivo TherapeuticsN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%BJDXBluejay Diagnostics18.47%GMVDG Medical Innovations5.72%NVIVQInvivo Therapeutics12.32%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%BJDXBluejay Diagnostics0.08%GMVDG Medical Innovations37.10%NVIVQInvivo Therapeutics2.45%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.78 million28.23 millionOptionableBJDXBluejay Diagnostics91.49 million551,000Not OptionableGMVDG Medical Innovations841.96 million1.24 millionNot OptionableNVIVQInvivo Therapeutics63.11 million3.03 millionN/AGMVD, NVIVQ, BJDX, and AFIB HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeGMVD, NVIVQ, BJDX, and AFIB Company DescriptionsAcutus Medical NASDAQ:AFIB$0.0025 +0.00 (+38.89%) As of 06/11/2025 02:22 PM EasternAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Bluejay Diagnostics NASDAQ:BJDX$1.73 -0.07 (-3.94%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.G Medical Innovations NASDAQ:GMVDG Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.Invivo Therapeutics NASDAQ:NVIVQ$0.37 0.00 (0.00%) As of 07/26/2024InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile Dave & Buster’s: Short-Covering Rally Signals Big Upside for PLAY GitLab: Buy It Low While You Still Can—Higher Prices Are Coming RKLB Breakout Fails Near Highs: Should Investors Be Concerned? Amazon Is on Track to Hit a Critical Level: Watch Out Tesla Stock: Why These 2 Downgrades Are Actually a Buy Signal The Other AI Chipmaker: Why Marvell's Dip Is a Buy Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
